Supplemental Table 9. Distribution of HDL particle sizes (absolute values).
Baseline | Week 12 | |
---|---|---|
Cholesterol particle size of HDL, nm | ||
Placebo | 10.64 (10.47, 10.85) | 10.64 (10.47, 10.89) |
Evolocumab | 10.63 (10.47, 10.81) | 10.73 (10.55, 10.94) |
Change from baseline, % | ||
Placebo | 0.00 (−0.74, 0.78) | |
Evolocumab | 0.84 (0.00, 1.62) |
Abbreviation: HDL, high-density lipoprotein. Data are expressed as median (1st quartile, 3rd quartile).